Atrial Flutter as the First Manifestation of Progressive Cardiac Conduction Disease in a Young Apparently Healthy Patient: А Case Report

I. Stepanenko 1 , D. Frolov 1 , V. Salukhov 1 , M. Didenko 2 , V. Kitsyshin 1 , Z. Khalaeva 1  und S. Kushnarev 3
  • 1 Molchanov First Department of Internal Medicine Postgraduate Training, Saint Petersburg, Russian Federation
  • 2 Kupriyanov First Department of Postgraduate Surgical Training, Saint Petersburg, Russian Federation
  • 3 Radiology Department, Saint Petersburg, Russian Federation

Abstract

We reported a case of a twenty-one-year-old man with an atrial flutter as the first manifestation of progressive cardiac conduction disease. The patient was admitted to the cardiology department due to complaints of shortness of breath and a decrease in exercise tolerance, which had happened after physical exercises (running). During ambulatory ECG monitoring persistent AFL was observed with atrial rate 262-297 bpm and ventricular rate 26-136 bpm (average 56 bpm). AV conduction was very variable – 4:1-14:1. The results of ambulatory ECG monitoring during the whole period of recording indicated signs of atrioventricular conduction disturbances. After cardioversion sinus rhythm was restored additional rhythm and conduction disorders were revealed. Ambulatory ECG monitoring was performed two weeks after the initial one, and throughout this recording were registered sinus rhythm on the background of first-degree AV block; transient Mobitz I AV block; and type 2 second-degree sinoatrial block. Trans-esophageal electrophysiology study was performed. During pharmacological denervation of the heart, signs of slowing of the atrioventricular conduction and sinus node recovery time persisted. These changes along with right bundle branch block were regarded as a progressive cardiac conduction disease with an apparently hereditary cause.

Falls das inline PDF nicht korrekt dargestellt ist, können Sie das PDF hier herunterladen.

  • 1. Michaëlsson M, Jonzon A, Riesenfeld T. Isolated congenital complete atrioventricular block in adult life. A prospective study. Circulation. 1995;92(3):442–9. https://doi.org/10.1161/01.cir.92.3.442

  • 2. Asatryan B, Medeiros-Domingo A. Molecular and genetic insights into progressive cardiac conduction disease. Euro-pace. 2019;21(8):1145–58. https://doi.org/10.1371/journal.pone.0174434

  • 3. Baruteau A-E, Probst V, Abriel H. Inherited progressive cardiac conduction disorders. Curr Opin Cardiol. 2015;30(1):33–9. https://doi.org/1097/HCO.0000000000000134

  • 4. Kiselev A, Mikhaylov E, Parmon E, Sjoberg G, Sejersen T, Tarnovskaya S, et al. Progressive cardiac conduction disease associated with a DSP gene mutation. Int J Cardiol. 2016;216:188–9. https://doi.org/10.1016/j.ijcard.2016.04.164

  • 5. Hothi SS, Ara F, Timperley J. p.Y1449C SCN5A mutation associated with overlap disorder comprising conduction disease, Brugada syndrome, and atrial flutter. J Cardiovasc Electrophysiol. 2015;26(1):93–7. https://doi.org/10.1111/jce.12470

  • 6. Lynch HT, Mohiuddin S, Sketch MH, Krush AJ, Carter S, Runco V. Hereditary progressive atrioventricular conduction defect. A new syndrome? JAMA. 1973;225(12):1465–70. https://doi.org/10.1001/jama.1973.03220400011003

  • 7. Schott J-J, Charpentier F, Marec HL. Progressive Cardiac Conduction Disease. In: Gussak I, Antzelevitch C, Wilde AAM, Friedman PA, Ackerman MJ, Shen W-K, editors. Electrical Diseases of the Heart: Genetics, Mechanisms, Treatment, Prevention. London: Springer; 2008. p. 564–76. https://doi.org/10.1007/978-1-84628-854-8_39

  • 8. Ghali WA, Wasil BI, Brant R, Exner DV, Cornuz J. Atrial flutter and the risk of thromboembolism: a systematic review and meta-analysis. Am J Med. 2005;118(2):101–7. https://doi.org/10.1016/j.amjmed.2004.06.048

  • 9. Mont L. ’Fight for sinus rhythm, or surrender?’…. Eur Heart J. 2014;35(22):1427–9. https://doi.org/10.1093/eurheartj/ehu099

  • 10. Ackerman MJ, Priori SG, Willems S, Berul C, Brugada R, Calkins H, et al. HRS/EHRA expert consensus statement on the state of genetic testing for the channelopathies and cardiomyopathies: this document was developed as a partnership between the Heart Rhythm Society (HRS) and the European Heart Rhythm Association (EHRA). Europace. 2011;13(8):1077–109. https://doi.org/10.1093/europace/eur245

OPEN ACCESS

Zeitschrift + Hefte

Suche